Cardiff Oncology, Inc. (FRA:XE7C)

Cardiff Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	148	279	60	59	222	520
Market Cap Growth	26.25%	366.18%	2.21%	-73.61%	-57.31%	5972.61%
Enterprise Value	97	225	-12	-46	107	491
Last Close Price	2.04	4.05	1.27	1.25	5.15	13.90
PS Ratio	345.99	422.72	135.50	162.04	702.51	1736.31
PB Ratio	3.55	3.48	0.95	0.59	1.80	4.96
P/TBV Ratio	3.55	3.48	0.95	0.59	1.80	4.96
EV/Sales Ratio	226.62	340.75	-	-	338.28	1640.66
Debt / Equity Ratio	0.02	0.02	0.03	0.03	0.02	0.01
Asset Turnover	0.01	0.01	0.01	0.00	0.00	0.01
Quick Ratio	4.14	6.92	7.25	13.58	21.55	21.46
Current Ratio	4.20	7.08	7.42	14.25	22.28	21.79
Return on Equity (ROE)	-102.71%	-59.51%	-47.07%	-31.37%	-21.07%	-28.50%
Return on Assets (ROA)	-52.99%	-34.01%	-28.69%	-18.77%	-12.69%	-16.14%
Return on Capital (ROIC)	-66.55%	-38.89%	-31.37%	-19.75%	-13.23%	-17.28%
Return on Capital Employed (ROCE)	-109.40%	-58.10%	-63.80%	-36.80%	-20.20%	-14.80%
Earnings Yield	-29.10%	-15.74%	-62.67%	-61.88%	-11.22%	-3.04%
FCF Yield	-24.38%	-13.08%	-47.59%	-55.68%	-9.22%	-2.60%
Buyback Yield / Dilution	-40.37%	-6.65%	-2.47%	-11.71%	-86.97%	-249.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.